Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment

J Neurol. 2013 Sep;260(9):2414-6. doi: 10.1007/s00415-013-7044-6. Epub 2013 Jul 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Amino Acid Sequence
  • Base Sequence
  • Child
  • DNA Mutational Analysis
  • Dopamine Agents / therapeutic use*
  • Exome
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Molecular Sequence Data
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / genetics
  • Mutation, Missense
  • Paraplegia / complications
  • Paraplegia / drug therapy
  • Paraplegia / genetics
  • Pedigree
  • Proteins / genetics*
  • Spastic Paraplegia, Hereditary / complications
  • Spastic Paraplegia, Hereditary / drug therapy
  • Spastic Paraplegia, Hereditary / genetics

Substances

  • Dopamine Agents
  • Proteins
  • WASHC5 protein, human
  • Levodopa

Supplementary concepts

  • Spastic Paraplegia Type 8